Home › Idiopathic Thrombocytopenic Purpura › Michigan
Idiopathic Thrombocytopenic Purpura clinical trials in Michigan
3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Michigan.
OM336 in Autoimmune Cytopenias
- University of Michigan, Ann Arbor
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT07083960Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- University of Michigan Health - Michigan Medicine - University Hospital-Investigational Site Number: 8400001, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Henry Ford Health, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.